CTRI/2020/07/026619尚未招募未知
octuria in men aged above 50 years with LUTS/BPH: Prevalence, its predictive factors and association with nocturnal polyuria and comparative analysis of outcome after tamsulosin or silodosin therapy by doing an open label randomized controlled study
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All men aged > 50 years with LUTS/BPH for at least 3 month duration having IPSS score of 8 or greater.
排除标准
- •1.Prostate cancer,
- •2.PSA > 4 ng/ml,
- •3.Urinary tract infection
- •4.Patients with h/o AUR or PUC placement or patients who are on PUC
- •5.Patients having renal failure or upper urinary tract dilatation.
- •6.Patients with h/o hematuria
- •7.Stricture urethra
- •8.Bladder calculus
- •9.Patients with GUTB
- •10.Patients with LUTS who are already on α-blockers within the past 1 month.
- •11.nervous system disease,
- •12.urolithiasis,
- •13.medical therapy that could affect the function of urination,
- •14.prostatic surgery, or pelvic surgery
研究者
相似试验
已完成
不适用
Prostate Bipolar Enucleation and Resection Versus Open ProstatectomyBenign Prostatic HyperplasiaNCT05416606Helwan University64
已完成
3 期
A-botulinic Toxin for Symptomatic Benign Prostate HypertrophyProstatic HyperplasiaNCT01275521University Hospital, Bordeaux127
招募中
不适用
Evaluation of the Optilume BPH Catheter System and the Rezum Water Vapor Therapy in Treating Benign Prostatic HyperplasiaBenign Prostatic Hyperplasia (BPH)Lower Urinary Track SymptomsNCT06769997Centre hospitalier de l'Université de Montréal (CHUM)100
Unknown
4 期
Efficacy of a Single Dose Dexamethasone in Reducing the Postembolization Syndrome in Men Undergoing Prostatic Artery Embolization for Benign Prostatic HyperplasiaProstatic HyperplasiaNCT04588857Rigshospitalet, Denmark60
终止
3 期
JALYN for Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)Chronic ProstatitisBenign Prostatic HyperplasiaNCT01830829Dr. J. Curtis Nickel1